- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
CustomVue offers good results in mixed astigmatism
Excellent visual outcomes can be achieved in subjects with mixed astigmatism when using the VISX wavefront platform's CustomVue iris registration system (AMO).
Excellent visual outcomes can be achieved in subjects with mixed astigmatism when using the VISX wavefront platform's CustomVue iris registration system (AMO), according to Baha Toygar and co-workers from the Dunya Eye Hospital, Istanbul, Turkey.
Sixteen eyes with mixed astigmatism were enrolled into the prospective study in which all LASIK procedures were performed by the same surgeon.
Three months following surgery, mean astigmatism had reduced from -3.14±1.06 D to -0.33±0.44 D. The majority of eyes (81%) had less than -0.50 D residual astigmatism and 87.5% had less than -1.0 D. Mean uncorrected and best corrected visual acuity (UCVA & BCVA) improved from 0.24±0.13 to 0.79±0.27 and from 0.84±0.20 to 0.95±0.11, respectively.
Overall, these results demonstrate that the VISX wavefront platform's CustomVue iris registration system can offer excellent visual outcomes for subjects with mixed astigmatism.
